Senate Republicans are crafting a legislative alternative to the House-passed American Health Care Act (AHCA) to repeal and the Affordable Care Act (ACA). They have been working on their legislation in secret and do not plan to release their bill to the public until days before a planned vote on June 28. While details about what is included in the Senate bill are scarce, we anticipate that, like the AHCA, it will impact patient protections and potentially lead to significant losses in coverage.
ACHA Board Member Michael Pernick Discusses the Threat of the American Health Care Act to People With Preexisting Conditions at Washington, D.C. Press Conference
Adult Congenital Heart Association Board Member Michael Pernick today joined Senator Dick Durbin (D-IL), Senator Angus King (I-ME) and Senator Brian Schatz (D-HI) to discuss the risks that the American Health Care Act poses to people with pre-existing conditions. You can view the video here, and Michael’s full comments are below.
- My name is Michael Pernick. I’m from Long Island. I was born with a congenital heart defect called Tetralogy of Fallot—you may have heard of it because it is the same heart defect as Jimmy Kimmel’s son, Billy.
Senate Sign-On Deadline: May 12, 2017
As Congress begins consideration of federal spending bills for Fiscal Year 2018, ACHA asks that you act today to urge your two Senators to sign the Durbin-Grassley Fiscal 2018 Appropriations Letter in support of funding for the CDC program to address the lifelong needs of Americans with congenital heart defects (CHDs). Members of Congress send letters outlining their funding priorities for the next year, and we want as many people to sign onto the letter as possible! The Durbin-Grassley letter requests robust federal support for CHD-related public health research and surveillance initiatives at the Centers for Disease Control and Prevention’s (CDC) National Center on Birth Defects and Developmental Disabilities (NCBDDD). Federal support is necessary to continue and expand upon these efforts to improve health outcomes and reduce medical costs!
On behalf of our staff and Board of Directors, we are proud to announce the hiring of our new President and CEO, Mark Roeder. He joins ACHA with an impressive 30-year career track record in nonprofit management for large, national health organizations as well as high-level corporate marketing and public relations.
Philadelphia, PA (February 1, 2017) – The Adult Congenital Heart Association (ACHA) announced today the launch of their Heart Month campaign – Every adult with CHD was once a child with CHD - this February is focusing on the importance of raising critical awareness of congenital heart disease (CHD) and lifelong care from childhood to adulthood.
On Thursday, Sept. 8, 2016, the House Energy & Commerce Committee is holding a hearing on the Congenital Heart Futures Re-authorization Act (CHFRA). As you know, the Adult Congenital Heart Association (ACHA) has been working hard since this bill’s introduction last fall to support its passage. This hearing is an important step towards enactment.
This ACHA-endorsed legislation reauthorizes the Congenital Heart Futures Act, enacted in 2010, that expanded the infrastructure to track congenital heart disease (CHD) at the Centers for Disease Control and Prevention (CDC) and increased research on CHD at the National Institutes of Health (NIH).
The Adult Congenital Heart Association (ACHA) announced today the launch of their ACHA ACHD Accreditation Program. This is a significant milestone as this program establishes a concrete set of criteria that strives to provide high quality care for adult congenital heart disease (ACHD) patients.
October 7-8, 2016, Doubletree Universal Studios Orlando
Submission Deadline: Now Closed
Abstracts are being accepted for the Research Symposium at ACHA’s 8th National conference. One moderated poster session will take place on Friday, October 7, 2016 from 4:30 p.m. – 6:00 p.m., highlighting 16-20 abstracts. Presenters are asked to discuss their work for five minutes, plus five minutes of time for directed questions and answers. Three abstracts will be chosen to be presented orally at the podium on Saturday morning, October 8, 2016. Podium presenters will receive a cash reward and a plaque.